Amgen Anniversary Brings New Battle To Supreme Court
A year after the U.S. Supreme Court rejected Amgen Inc.'s effort to raise the certification standards for securities fraud plaintiffs, attorneys say the case has helped pave the way for next...To view the full article, register now.
Already a subscriber? Click here to view full article